Investor List:

Top Therapeutics Pre-Seed Investors (188)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Alex Davidov, General Partner at Abstract Ventures
Alex Davidov
Abstract Ventures·General Partner
Sweet spot: $500K
Range: $250K - $750K
Investors in San Francisco (CA)
Investors in Insurance (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in FinTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Insurance (Seed), Investors in SaaS (Seed), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Seed), Investors in Web3/Crypto (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Insurance (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in BioTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in SaaS (Pre-seed), Investors in Insurance (Pre-seed), Investors in FinTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Dave Morin, Managing Partner at Offline Ventures
Dave Morin
Offline Ventures·Managing Partner
Sweet spot: $1M
Range: $500K - $5.0M
Investors in SF Bay Area (CA), Investors in California
Investors in Robotics (Seed), Investors in EnergyTech (Seed), Investors in Social Networks (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Web3/Crypto (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Web3/Crypto (Seed), Investors in EnergyTech (Seed), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Social Networks (Seed), Investors in Robotics (Seed), Investors in Space (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Seed), Investors in EnergyTech (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in Space (Pre-seed), Investors in Robotics (Pre-seed), Investors in Social Networks (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in Web3/Crypto (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Space (Pre-seed), Investors in Social Networks (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Seed)
Photo of Alexander Hall-Daniels, Associate at IndieBio
Alexander Hall-Daniels
IndieBio·Associate
Sweet spot: $525K
Range: $275K - $525K
Investors in United States, Investors in New York
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Hardware (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Ketan Yerneni, Principal at KdT Ventures
Ketan Yerneni
KdT Ventures·Principal
Sweet spot: $850K
Range: $750K - $1M
Investors in Chicago (IL)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Seed), Investors in Midwest (Other Lists), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed)
Photo of Zdenek Fred Fous, General Partner at PurposeTech
Zdenek Fred Fous
PurposeTech·General Partner
Sweet spot: $100K
Range: $100K - $200K
Investors in Europe
Photo of Faisal Al Hammadi, Managing Partner at Further Ventures
Faisal Al Hammadi
Further Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Middle East
Investors in MarketingTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in ConstructionTech (Seed), Investors in LegalTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in LegalTech (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Supply Chain Tech (Pre-seed), Investors in Supply Chain Tech (Seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in FinTech (Seed)
Photo of Thomas Schulz, Managing Partner at healthetia
Thomas Schulz
healthetia·Managing Partner
Sweet spot: $25K
Range: $10K - $100K
Investors in Europe, Investors in Austria, Investors in Germany, Investors in Switzerland